We have located links that may give you full text access.
Prevalence of Polycystic Ovarian Syndrome in Young and Adolescent Transmasculine Patients Presenting for Gender Affirming Care.
Journal of Pediatric and Adolescent Gynecology 2023 September 10
STUDY OBJECTIVE: To determine the incidence of PCOS and hyperandrogenism amongst adolescent transmasculine patients presenting to a tertiary care referral center for gender affirming care.
METHODS: This was a retrospective study of adolescent transmasculine patients presenting to Cleveland Clinic for gender affirming hormone therapy (GAHT). The diagnostic criteria were adolescent-specific as defined by the international evidence-based guideline for PCOS management and included oligomenorrhea and/or anovulation with clinical and/or biochemical hyperandrogenism after exclusion of other androgen excess disorders.
RESULTS: The described transgender population had a prevalence of PCOS of 23.8%. The transmasculine patients who met criteria for PCOS had both higher levels of androgens in addition to higher BMIs when compared to the patients without PCOS. Additionally, the PCOS patients had higher rates of dyslipidemia.
CONCLUSION: The prevalence of PCOS amongst transmasculine patients may be higher compared to the general population. Transmasculine patients with PCOS should be counseled regarding the long-term health implications associated with PCOS and screened appropriately to minimize risks.
METHODS: This was a retrospective study of adolescent transmasculine patients presenting to Cleveland Clinic for gender affirming hormone therapy (GAHT). The diagnostic criteria were adolescent-specific as defined by the international evidence-based guideline for PCOS management and included oligomenorrhea and/or anovulation with clinical and/or biochemical hyperandrogenism after exclusion of other androgen excess disorders.
RESULTS: The described transgender population had a prevalence of PCOS of 23.8%. The transmasculine patients who met criteria for PCOS had both higher levels of androgens in addition to higher BMIs when compared to the patients without PCOS. Additionally, the PCOS patients had higher rates of dyslipidemia.
CONCLUSION: The prevalence of PCOS amongst transmasculine patients may be higher compared to the general population. Transmasculine patients with PCOS should be counseled regarding the long-term health implications associated with PCOS and screened appropriately to minimize risks.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app